Dr. Catherine Brignoni is a Palm Desert, California based neurologist with 24 years of experience in Neurology. She completed her graduation from University Of Illinois College Of Med (chi/peor/rock/chm-urb) in 2000. She is also affiliated with hospitals like and . She accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Dr. Catherine Brignoni is A96802 for Neurology in California. Her current practice location is 72670 Fred Waring Dr Ste 202, Palm Desert. Patients can reach her at 760-340-4300 or can fax her at 760-340-4322. Dr. Catherine Brignoni is M.D. in Neurology and her NPI number (Unique professional ID assigned by NPPES) is 1114982048. Dr. Catherine Brignoni specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Catherine Brignoni speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Dr. Catherine Brignoni
Specialization:
Neurology
Gender:
Female
Credentials:
M.D.
Experience:
24+ years
Medical School Attended:
University Of Illinois College Of Med (chi/peor/rock/chm-urb)
Graduation Year:
2000
Accepts Medicare Assignment:
Yes
Practice Address:
72670 Fred Waring Dr Ste 202, Palm Desert, California, 92260-5013
Phone:
760-340-4300
Fax:
760-340-4322
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
6406894716
Enrollment ID:
I20071004000529
NPI Number:
1114982048
NPI Enumeration Date:
20 Apr, 2006
NPI Last Update On:
31 Jan, 2023
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Catherine Brignoni are as mentioned below.
License Number
Specialization
State
Status
A96802
Neurology
California
Primary
2021050442
Neurology
Missouri
Secondary
0101241585
Neurology
Virginia
Secondary
036113019
Neurology
Illinois
Secondary
Hospital Affiliation:
Surgeons are affiliated to many hospitals whom they worked with in the past or are presently working with. One surgeon can be affiliated to four to five hospitals at a time.
Hospital Name (CCN)
State
Hospital Type
(420085)
Myrtle beach, SC
Acute Care Hospital
(340015)
Salisbury, NC
Acute Care Hospital
(050573)
Rancho mirage, CA
Acute Care Hospital
(340183)
Huntersville, NC
Acute Care Hospital
(340171)
Matthews, NC
Acute Care Hospital
Group Practice:
Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name
with which Dr. Catherine Brignoni is associated with along with the number of members in that group.
Organization Name (Group PAC ID)
Members
Sentara Medical Group (8921903923)
933
()
Novant Medical Group Inc (1153234893)
1918
Other Medical Identifiers:
Other legacy medical identifiers associated with Dr. Catherine Brignoni such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
036113019
Medicaid
Illinois
200106554
Medicaid
Missouri
A96802
Other
California
STATE MEDICAL LICENSE
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Catherine Brignoni Po Box 626, Rancho Mirage, California
Zip:
92270-0626
Phone Number:
760-340-4300
Fax Number:
760-340-4322
Patients can reach Dr. Catherine Brignoni at 72670 Fred Waring Dr Ste 202, Palm Desert, California or can call to book an appointment on 760-340-4300.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.